Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine WRAPUP’25 Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Indian Startups Secure USD 6.7 Bn in H1 2025 Amid Growing IPO Momentum

    Indian Startups Secure $6.7 Bn in H1 2025 Amid Growing IPO Momentum


    Finance Outlook India Team | Wednesday, 02 July 2025

    Venture capital inflows into Indian startups remained consistent in the first half of calendar year 2025, with startups raising nearly $7 billion. Startup funding in 2025 is closely tracking last year's trend, thanks to several deals worth more than $100 million, including four that exceeded $200 million. Furthermore, tighter layoff controls, an increase in IPO filings, and the formation of large funds have all contributed to overall stability.

    Key Highlights

    • Indian startups raised $5.7 billion across 470 deals in H1 2025, marking an 8% year‑on‑year growth.
    • Despite macroeconomic headwinds, IPO momentum picked up with Pine Labs filing IPO and HDB Financial debut.

    Overview

    According to data compiled by TheKredible, Indian startups received approximately $6.72 billion in funding in the first half of 2025. This figure included 148 growth and late-stage deals totaling $5.15 billion, as well as 404 early-stage deals worth $1.57 billion. In addition, there were 74 undisclosed transactions during this time period. 

    During this time, five startups joined the unicorn club: Jumbotail, Drools, Porter, Netradyne, and Juspay. Interestingly, they are all based in Bengaluru.

    According to a recent Tracxn report, India is the world's third largest recipient of startup funding, trailing only the United States and the UK. However, the report oddly excluded China, which raised $6.9 billion in the first quarter of 2025 alone.

    Also Read:HDB Financial IPO Day 3: Subscribed Nearly 4x, GMP Sees an Uptick 

    Year-on-year and month-on-month trends

    The H1 funding closely mirrors the same period in 2024, when the ecosystem received approximately $7 billion over six months. While funding in the last six months has surpassed the H1 2023 numbers, it is still significantly lower than the $20 billion raised in H1 2022 and $13 billion in H1 2021. On a month-to-month basis, June saw just under $1 billion in funding, a decrease from $1.14 billion raised in May. This is the third time that total monthly funding has fallen below $1 billion in the first half of 2025. 



    Read More:

    Cabinet Extends Atal Pension Yojana Support Till FY31

    Eternal Q3 FY26 Revenue at Rs 16,315 Cr; Deepinder Goyal Steps Down

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us